期刊文献+

利培酮治疗儿童孤独症研究进展 被引量:2

利培酮治疗儿童孤独症研究进展
原文传递
导出
摘要 儿童孤独症是一种严重的神经精神发育障碍疾病,一般3岁前发病。主要特征为社会交往障碍、语言交流技巧障碍,以及重复刻板行为和兴趣狭窄。目前,由于病因尚未明确,儿童孤独症的治疗主要以康复教育训练为主,药物治疗为辅,主要用以改善患儿情绪和行为症状。药物治疗中以利培酮最为成功。现将近年来利培酮在儿童孤独症中的研究进展做一综述。
出处 《中国实用儿科杂志》 CSCD 北大核心 2009年第8期651-652,共2页 Chinese Journal of Practical Pediatrics
关键词 儿童孤独症 利培酮 非典型抗精神病药 childhood autism risperidone atypical antipsychotic drugs
  • 相关文献

参考文献9

  • 1McCracken JT, McGough J, Shah B, et al. Risperidone in children with autism and serious behavioral problems [J]. N Engl J Med,2002,347(5) :314-321.
  • 2Fombonne E. Risperidone improves restricted, repetitive, and stereotyped behaviour in autistic children and adolescents [J]. Evidence-Based Mental Health, 2006,9 ( 1 ) : 6.
  • 3Nagaraj R, Singhi P, Malhi P. Risperidone in children with autism: randomized, placebo-controlled, double-blind study[J]. J Child Neurol, 2006,21 (6) : 450-455.
  • 4Boon YV, Tarugsa J, Suwanwattana C, et al. Risperidone in the treatment of autistic Thai children under 4 years of age [J ]. J Med Assoc Thai, 2002,85 (2) : 784 -789.
  • 5Martin A, Scahill L, Anderson GM, et al. Weight and leptin changes among risperidone-treated youths with autism: 6-month prospective data [J]. Am J Psychiatry, 2004, 161 (6) : 1125-1127.
  • 6Shea S, Turgay A, Carroll A, et al. Risperidone in the treatment of disruptive behavioral symptoms in children with autistic and other pervasive developmental disorders [J]. Pediatrics, 2004, 114 (5):634-641.
  • 7Anderson GM, Scahill L, McCracken JT, et al. Effects of short-and long-term risperidone treatment on prolactin levels in children with autism [J]. Biol Psychiatry , 2007, 61 (4) : 545-550.
  • 8Malone R, Maislin G, Choudhury M, et al. Risperidone treatment in children and adolescents with autism: short-and long-term safety and effectiveness [J ]. J Am Acad of Child Adolesc Psychiatry, 2002, (2) : 140-147.
  • 9郭兰婷.利培酮对儿童孤独症的开放性治疗[J].中国神经精神疾病杂志,2001,27(4):291-293. 被引量:15

二级参考文献8

  • 1[1]Cook EH Jr, Courchesne R, Lord C, et al. Evidence of linkage between the serotonin transporter and autistic disorder. Mol Psychiatry, 1997, 2(3): 247
  • 2[2]Herault J, Petit E, Martineau J, et al. Serotonin and autism: biochemical and molecular biology features. Psychiatry Res, 1996, 65(1): 33
  • 3[3]Purdon SE, Lit W, Labelle A, et al. Risperidone in the treatment of pervasive developmental disorder. Can J Psychiatry, 1994, 39(7): 400
  • 4[4]McDougle CJ, Holmes JP, Carlosn DC, et al. A double-blind, placebocontrolled study of risperidone in adults with autistic disorder and other pervasive developmental disorders. Arch Gen Psychiatry, 1998, 55(7):633
  • 5[5]Nicolson R, Awad G, Sloman L. An open trial of risperidone in young autistic children. J Am Acad Child Adolesc Psychiatry, 1998, 37(4):372
  • 6[6]Perry R, Pataki C, Munoz; Silva DM, et al. Risperidone in children and adolescents with pervasive developmental disorder: pilot trial and followup. J Child Adolesc Psychopharmacol, 1997, 7(3): 167
  • 7[7]McDougle C J, Holmes JP, Bronson MR, et al. Risperidone treament of children and adolescents with pervasive developmental disorders: a prospective open-label study. Am Acad Child Adolesc Psychiatry, 1997,36(5): 685
  • 8[8]Findling RL, Maxwell K, Wiznitzer M. An open clinical trial of risperidone monotherapy in young children with autistic disorder. Psychopharmacol Bull, 1997, 33(1): 155

共引文献14

同被引文献26

引证文献2

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部